Document Detail


Evaluation of minoxidil.
MedLine Citation:
PMID:  6994495     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The chemistry, pharmacokinetics, mechanism of action, clinical studies, adverse effects, toxicology, indications, contraindications, drug interactions, and dosing of minoxidil, a recently approved antihypertensive agent, are reviewed. Minoxidil is an orally effective vasodilator that selectively relaxes peripheral arteriolar smooth muscle, Reflex tachycardia, renin stimulation, and sodium retention occur when minoxidil is used and so it requires the concomitant use of a diuretic and a sympathoplegic agent, usually a beta blocker. Hirsutism and pericardial effusions are additional adverse effects. Minoxidil is indicated in the management of severe hypertension in patients who do not respond to standard antihypertensive agents. In controlled and unctrolled studies, minoxidil was effective in patients with hypertension secondary to renal or renovascular disease and in patients with essential hypertension. Minoxidil is a potent antihypertensive agent with adverse effects that limit its use to patients resistant or intolerant to other drugs.
Authors:
D D Miller; D W Love
Related Documents :
10672135 - Evaluation of a computer-based decision support system for treatment of hypertension wi...
22849275 - Use of antimicrobial agents in aquaculture.
12929905 - The right drug and the right dose.
22570515 - Comparative qsar analysis of cyclo-oxygenase2 inhibiting drugs.
9353655 - Economic modelling of the gateway effect.
24568455 - Plga-based nanoparticles as cancer drug delivery systems.
Publication Detail:
Type:  Clinical Trial; Journal Article; Review    
Journal Detail:
Title:  American journal of hospital pharmacy     Volume:  37     ISSN:  0002-9289     ISO Abbreviation:  Am J Hosp Pharm     Publication Date:  1980 Jun 
Date Detail:
Created Date:  1980-09-28     Completed Date:  1980-09-28     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370474     Medline TA:  Am J Hosp Pharm     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  808-14     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Animals
Child
Clinical Trials as Topic
Drug Administration Schedule
Humans
Hypertension / drug therapy
Kinetics
Minoxidil / adverse effects,  metabolism,  pharmacology,  therapeutic use*
Pyrimidines / therapeutic use*
Chemical
Reg. No./Substance:
0/Pyrimidines; 38304-91-5/Minoxidil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Human neutral alpha-glucosidase C: genetic polymorphism including a "null" allele.
Next Document:  Treatment of psoriasis.